@article {1058,
	title = {Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.},
	journal = {The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions},
	volume = {17},
	year = {2008},
	month = {2008 Mar-Apr},
	pages = {116-20},
	abstract = {To examine long-term outcomes with primary care office-based buprenorphine/naloxone treatment, we followed 53 opioid-dependent patients who had already demonstrated six months of documented clinical stability for 2-5 years. Primary outcomes were retention, illicit drug use, dose, satisfaction, serum transaminases, and adverse events. Thirty-eight percent of enrolled subjects were retained for two years. Ninety-one percent of urine samples had no evidence of opioid use, and patient satisfaction was high. Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment.},
	keywords = {Adult, Buprenorphine, Combined Modality Therapy, Counseling, Cross-Sectional Studies, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Follow-Up Studies, Heroin Dependence, Humans, Long-Term Care, Male, Middle Aged, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Patient Dropouts, Primary Health Care, Substance Abuse Detection, Treatment Outcome},
	issn = {1521-0391},
	doi = {10.1002/hpm.1029},
	author = {Fiellin, David A and Moore, Brent A and Sullivan, Lynn E and Becker, William C and Pantalon, Michael V and Chawarski, Marek C and Barry, Declan T and O{\textquoteright}Connor, Patrick G and Schottenfeld, Richard S}
}
